Wednesday, August 20, 2014

FDA Sends Warning Letter to Compounding Firm

FDA Sends Warning Letter to Compounding Firm
Today - 20:09 GMT
The U.S. Food and Drug Administration has sent a letter to a Lexington pharmaceutical firm that compounds drugs for horses notifying the firm that tests show its drug products are "adulterated and misbranded" under the federal Food, Drug, and Cosmetic Act. In a letter to Wickliffe Pharmaceutical Inc. and its president/owner Jacqueline S. Bernard, the FDA's district … (continue reading)

No comments: